NYXOAH SA - ORDINARY SHARES

Nyxoah Announces Preliminary Results for the Third Quarter of 2026 and Adjusts Revenue Guidance for 2026

19 Oct 2026 08:00:00 Источник Nasdaq GlobeNewswire

Full 12-Month Data from the ACCCESS U.S. Pivotal Study in Complete Concentric Collapse Patients Presented at ISSS 2026

15 Oct 2026 16:05:00 Источник Nasdaq GlobeNewswire

Nyxoah Appoints Liam Kelly as Chief Executive Officer

28 Sep 2026 16:30:00 Источник Nasdaq GlobeNewswire

Nyxoah Announces Chief Financial Officer Transition

21 Sep 2026 16:01:00 Источник Nasdaq GlobeNewswire

Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® System

07 Sep 2026 16:05:00 Источник Nasdaq GlobeNewswire

Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2025 and Provides Revenue Guidance for the First Quarter of 2026

12 Jan 2026 16:05:00 Источник Nasdaq GlobeNewswire

Publication relating to transparency notification

12 Jan 2026 01:00:00 Источник Nasdaq GlobeNewswire

Nyxoah to Present at the 44th Annual J.P. Morgan Healthcare Conference

29 Dec 2025 16:05:00 Источник Nasdaq GlobeNewswire

Nyxoah Announces Issuance of First Tranche of Convertible Bonds

19 Dec 2025 16:05:00 Источник Nasdaq GlobeNewswire

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands

17 Dec 2025 01:05:00 Источник Nasdaq GlobeNewswire

Publication relating to transparency notifications

02 Dec 2025 16:30:00 Источник Nasdaq GlobeNewswire

Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference

27 Nov 2025 16:05:00 Источник Nasdaq GlobeNewswire

Nyxoah’s Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule

26 Nov 2025 01:45:00 Источник Nasdaq GlobeNewswire

Information on the total number of voting rights and shares

20 Nov 2025 16:30:00 Источник Nasdaq GlobeNewswire

Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio

13 Nov 2025 19:30:00 Источник Nasdaq GlobeNewswire

Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio

13 Nov 2025 16:35:48 Источник Nasdaq GlobeNewswire

Nyxoah Reports Third Quarter 2025 Financial and Operating Results

13 Nov 2025 16:12:16 Источник Nasdaq GlobeNewswire

Nyxoah to Participate in the Stifel 2025 Healthcare Conference

03 Nov 2025 16:05:00 Источник Nasdaq GlobeNewswire

Nyxoah to Release Third Quarter 2025 Financial Results on November 13, 2025

30 Oct 2025 17:10:00 Источник Nasdaq GlobeNewswire

Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® System

06 Oct 2025 01:00:00 Источник Nasdaq GlobeNewswire